News
-
-
-
PRESS RELEASE
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development -
REGULATED PRESS RELEASE
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million. Collaboration for commercialization and clinical development announced -
-
-
PRESS RELEASE
EQS-Adhoc: Dexus Finance Pty Limited: Portfolio valuation update and estimated distribution details - 30 June 2024
Dexus Finance Pty Limited announces portfolio valuation update: decrease of circa $1.3 billion (9.0%) in book values for the six months to 30 June 2024. Estimated distribution details available on 20 August 2024 -
-
-